Efficacy and Safety of Bongros-BMP Compared to Bio-oss for Regeneration of Alveolar Bone Tissue After Maxillary Sinus Floor Augmentation

Daewoong Pharmaceutical

Status and phase: Completed; Phase 3

Conditions: Regeneration of Alveolar Tissue After Maxillary Sinus Floor Augmentation

Treatments: Drug: Bio-oss; Drug: Novosis(bongros/BMP-2)

Study type: Interventional

Funder types: Industry; Other

Identifiers

NCT01634308

BA05-CP01

Details and patient eligibility

About

The purpose of this Clinical study was to evaluate the Efficacy and Safety of bongros-BMP compared to Bio-oss for Regeneration of alveolar bone tissue after Maxillary sinus floor augmentation.

Sex: All

Ages: 40 to 70 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Trial design

0 participants in 2 patient groups

Novosis(bongros/BMP-2)

Experimental group

Treatment:

Drug: Novosis(bongros/BMP-2)

Bio-oss

Active Comparator group

Treatment:

Drug: Bio-oss